Clinical Trial Update: Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing long-term efficacy and safety of aflibercept IVT for diabetic macular edema after completion of VISTA-DME.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)
• EYLEA (Aflibercept)

Snippet

Sponsor: Greater Houston Retina Research | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED | Results posted: 2018-06-07